IT News Online - Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc.

Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc.

Related Keywords

United States ,Grandview ,Manitoba ,Canada ,Germany ,American ,Michael Redmond ,National Research Council Of Canada ,Exchange Commission ,Odyssey Health Inc ,Neurological Drug Technology Pipeline Including Concussion ,Odyssey Group International Inc ,National Institutes Of Health ,Odyssey Health Closes Asset Sale ,Oragenics Inc ,Grandview Research ,Odyssey Health ,Asset Purchase Agreement ,Oragenic Seriesf Preferred Stock ,Chief Executive Officer ,Mild Traumatic Brain Injury ,Chronic Traumatic Encephalopathy ,Health Inc ,Odyssey Group International ,National Institutes ,National Research Council ,Securities Litigation Reform Act ,Odyssey Health Closes Asset Sale Of Its Neurological Drug Technology Pipeline Including Concussion Candidate With Oragenics ,Nc ,India ,Sia ,Australia ,Middle East ,Europe ,N America ,S America ,Frica ,Hardware ,Software ,Internet ,Aming ,Elecom ,Inance ,G ,Riple Play ,Mail ,Ard Drives ,Chip ,Rocessor ,Emicomductor ,Ireless ,I Fi ,Luetooth ,Sb ,Server ,Orkstation ,C ,Computer ,Technology ,Electronics ,Ellphones ,Prs ,Rojan ,Eforms ,Oip ,P3 ,Windows ,Inux ,